Cardiac actions of protein kinase C isoforms

Physiology

Volumn 27, Issue 3, 2012, Pages 130-139

  Steinberg, Susan F ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; PROTEIN KINASE C;

ANIMAL; HEART MUSCLE; HUMAN; METABOLISM; PHOSPHORYLATION; REVIEW;

ANIMALS; HUMANS; ISOENZYMES; MYOCARDIUM; PHOSPHORYLATION; PROTEIN KINASE C;

EID: 84862235945     PISSN: 15489213     EISSN: 15489221     Source Type: Journal    
DOI: 10.1152/physiol.00009.2012     Document Type: Review

References (82)

1. 2+ current from neonatal mouse ventricular myocytes by constitutively active PKC-β II. Am J Physiol Cell Physiol 282: C768-C774, 2002.
2. Apostolatos A, Song S, Acosta S, Peart M, Watson JE, Bick-ford P, Cooper DR, Patel NA. Insulin promotes neuronal survival via the alternatively spliced protein kinase C-δ II (PKCSII) isoform. J Biol Chem 287: 9299-9310, 2012.
3. Apostolatos H, Apostolatos A, Vickers T, Watson JE, Song S, Vale F, Cooper DR, Sanchez-Ramos J, Patel NA. Vitamin A metabolite, all-trans-retinoic acid, mediates alternative splicing of protein kinase C-δVIII (PKCδVIII) isoform via splicing factor SC35. J Biol Chem 285: 25987-25995, 2010.
4. Bates E, Bode C, Costa M, Gibson CM, Granger C, Green C, Grimes K, Harrington R, Huber K, Kleiman N, Mochly-Rosen D, Roe M, Sadowski Z, Solomon S, Widimsky P. Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Circulation 117: 886-896, 2008.
5. 2+-sensitive isoforms in the failing human heart. Circulation 99: 384-391, 1999.
6. Bowman JC, Steinberg SF, Jiang T, Gennan D, Fishman GI, Buttrick PM. Expression of protein kinase C-β in the heart causes hypertrophy in adult mice and sudden death in neonates. J Clin Invest 100: 2189-2195, 1997.
7. Braz JC, Bueno OF, De Windt LJ, Molkentin JD. PKCa regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2). J Cell Biol 156: 905-919, 2002.
8. Braz JC, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R, Kimball TF, Lorenz JN, Nairn AC, Liggett SB, Bodi I, Wang S, Schwartz A, Lakatta EG, Paoli-Roach AA, Robbins J, Hewett TE, Bibb JA, Westfall MV, Kranias EG, Molkentin JD. PKC-a regulates cardiac contractility and propensity toward heart failure. Nat Med 10: 248-254, 2004.
9. Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, Mochly-Rosen D. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 321: 1493-1495, 2008.
10. Chen L, Hahn H, Wu G, Chen CH, Liron T, Schechtman D, Cavallaro G, Banci L, Guo Y, Bolli R, Dorn GW, Mochly-Rosen D. Opposing cardioprotective actions and parallel hypertrophic effects of δ PKC and e{open} PKC. Proc Natl Acad Sci USA 98: 11114-11119, 2001.
11. Cheng N, He R, Tian J, Dinauer MC, Ye RD. A critical role of protein kinase Cδ activation loop phosphorylation in formyl-methionyl-leucyl-phenylalanine-induced phosphorylation of p47phox and rapid activation of nicotinamide adenine dinu-cleotide phosphate Oxidase. J Immunol 179: 7720-7728, 2007.
12. Churchill EN, Qvit N, Mochly-Rosen D. Rationally designed peptide regulators of protein kinase C. Trends Endocrinol Metab 20: 25-33, 2009.
13. Churchill EN, Szweda LI. Translocation of δPKC to mitochondria during cardiac reperfusion enhances superoxide anion production and induces loss in mitochondrial function. Arch Biochem Biophys 439: 194-199, 2005.
14. Connelly KA, Kelly DJ, Zhang Y, Prior DL, Advani A, Cox AJ, Thai K, Krum H, Gilbert RE. Inhibition of protein kinase C-(3 by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy. Circ Heart Fail 2: 129-137, 2009.
15. Davidoff AJ, Davidson MB, Carmody MW, Davis ME, Ren J. Diabetic cardiomyocyte dysfunction and myocyte insulin resistance: role of glucose-induced PKC activity. Mol Cell Biochem 262: 155-163, 2004.
16. Disatnik MH, Buraggi G, Mochly-Rosen D. Localization of protein kinase C isozymes in cardiac myocytes. Exp Cell Res 210: 287-297, 1994.
17. Dorn GW, Souroujon MC, Liron T, Chen CH, Gray MO, Zhou HZ, Csukai M, Wu G, Lorenz JN, Mochly-Rosen D. Sustained in vivo cardiac protection by a rationally designed peptide that causes e protein kinase C translocation. Proc Natl Acad Sci USA 96: 12798-12803, 1999.
18. Ghayur T, Hugunin M, Talanian RV, Ratnofsky S, Quinlan C, EmotoY, Pandey P, Datta R, Huang Y, Kharbanda S, Allen H, Kamen R, Wong W, Kufe D. Proteolytic activation of protein kinase C δ by an ICE/CED 3-like protease induces characteristics of apoptosis. J Exp Med 184: 2399-2404, 1996.
19. Goldberg M, Zhang HL, Steinberg SF. Hypoxia alters the subcellular distribution of protein kinase C isoforms in neonatal rat ventricular myocytes. J Clin Invest 99: 55-61, 1997.
20. Gray MO, Zhou HZ, Schafhalter-Zoppoth I, Zhu P, Mochly-Rosen D, Messing RO. Preservation of base-line hemodynamic function and loss of inducible cardioprotection in adult mice lacking protein kinase C-e. J Biol Chem 279: 3596-3604, 2004.
21. Guo J, Cong L, Rybin VO, Gertsberg Z, Steinberg SF. Protein kinase C-δ regulates the subcellular localization of Shc in H2O2-treated cardiomyo-cytes. Am J Physiol Cell Physiol 299: C770-C778, 2010.
22. Guo J, Gertsberg Z, Ozgen N, Sabri A, Steinberg SF. Protein kinase D isoforms are activated in an agonist-specific manner in cardiomyocytes. J Biol Chem 286: 6500-6509, 2011.
23. Guo J, Sabri A, Elouardighi H, Rybin V, Steinberg SF. Alpha1-adrenergic receptors activate AKT via a Pyk2/PDK-1 pathway that is tonically inhibited by novel protein kinase C isoforms in cardiomyocytes. Circ Res 99: 1367-1375, 2006.
24. Harrison BC, Kim MS, van Rooij E, Plato CF, Papst PJ, Vega RB, McAnally JA, Richardson JA, Bassel-Duby R, Olson EN, McKinsey TA. Regulation of cardiac stress signaling by protein kinase D1. Mol Cell Biol 26: 3875-3888, 2006.
25. Heidkamp MC, Bayer AL, Martin JL, Samarel AM. Differential activation of mitogen-activated protein kinase cascades and apoptosis by protein kinase c e{open} and δ in neonatal rat ventricular myocytes. Circ Res 89: 882-890, 2001.
26. Hidalgo C, Hudson B, Bogomolovas J, Zhu Y, Anderson B, Greaser M, Labeit S, Granzier H. PKC phosphorylation of titin's PEVK element: a novel and conserved pathway for modulating myocardial stiffness. Circ Res 105: 631-638, 17, 2009.
27. Hoshi N, Langeberg LK, Gould CM, Newton AC, Scott JD. Interaction with AKAP79 modifies the cellular pharmacology of PKC. Mol Cell 37: 541-550, 2010.
28. 2+ transients of mouse heart myocytes conditionally expressing PKCβ. Am J Physiol Cell Physiol 280: C1114-C1120, 2001.
29. Inagaki K, Chen L, Ikeno F, Lee FH, Imahashi K, Bouley DM, Rezaee M, Yock PG, Murphy E, Mochly-Rosen D. Inhibition of δ-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation 108: 2304-2307, 2003.
30. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL. Preferential elevation of protein kinase C isoform β-II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 89: 11059-11063, 1992.
31. Kang MY, Zhang Y, Matkovich SJ, Diwan A, Chishti AH, Dorn GW. Receptor-independent cardiac protein kinase Cα activation by calpain-mediated truncation of regulatory domains. Circ Res 107: 903-912, 2010.
32. Khasar SG, Lin YH, Martin A, Dadgar J, McMahon T, Wang D, Hundle B, Aley KO, Isenberg W, McCarter G, Green PG, Hodge CW, Levine JD, Messing RO. A novel nociceptor signaling pathway revealed in protein kinase Ce mutant mice. Neuron 24: 253-260, 1999.
33. Kheifets V, Bright R, Inagaki K, Schechtman D, Mochly-Rosen D. Protein kinase Cδ-annexin V interaction: a required step in SPKC translocation and function. J Biol Chem 281: 23218-23226, 2006.
34. Kheifets V, Mochly-Rosen D. Insight into intra-and inter-molecular interactions of PKC: design of specific modulators of kinase function. Pharmacol Res 55: 467-476, 2007.
35. Kishimoto A, Mikawa K, Hashimoto K, Yasuda I, Tanaka S, Tominaga M, Kuroda T, Nishizuka Y. Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (cal-pain). J Biol Chem 264: 4088-4092, 1989.
36. Klein G, Schaefer A, Hilfiker-Kleiner D, Opper-mann D, Shukla P, Quint A, Podewski E, Hilfiker A, Schroder F, Leitges M, Drexler H. Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCe{open}. Circ Res 96: 748-755, 2005.
37. Konishi H, Tanaka M, Takemura Y, Matsuzaki H, Ono Y, Kikkawa U, Nishizuka Y. Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc Natl Acad Sci USA 94: 11233-11237, 1997.
38. Konishi H, Yamauchi E, Taniguchi H, Yamamoto T, Matsuzaki H, Takemura Y, Ohmae K, Kikkawa U, Nishizuka Y. Phosphorylation sites of protein kinase Cδ in H2O2-treated cells and its activation by tyrosine kinase in vitro. Proc Natl Acad Sci USA 98: 6587-6592, 2001.
39. 2+ sensitivity in human myocardium. Basic Res Cardiol 105: 289-300, 2010.
40. Kostelecky B, Saurin AT, Purkiss A, Parker PJ, McDonald NQ. Recognition of an intra-chain tandem 14-3-3 binding site within PKCe{open}. EMBO Rep 10: 983-989, 2009.
41. Lee JY, Chiu YH, Asara J, Cantley LC. Inhibition of PI3K binding to activators by serine phosphorylation of PI3K regulatory subunit p85α Src ho-mology-2 domains. Proc Natl Acad Sci USA 108: 14157-14162, 2011.
42. Leitges M, Gimborn K, Elis W, Kalesnikoff J, Hughes MR, Krystal G, Huber M. Protein kinase C-δ is a negative regulator of antigen-induced mast cell degranulation. Mol Cell Biol 22: 3970-3980, 2002.
43. Leitges M, Mayr M, Braun U, Mayr U, Li C, Pfister G, Ghaffari-Tabrizi N, Baier G, Hu Y, Xu Q. Exacerbated vein graft arteriosclerosis in protein kinase Cδ-null mice. J Clin Invest 108: 1505-1512, 2001.
44. Liu Q, Chen X, MacDonnell SM, Kranias EG, Lorenz JN, Leitges M, Houser SR, Molkentin JD. Protein kinase Cα, but not PKCβ or PKC7, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach. Circ Res 105: 194-200, 2009.
45. Lu W, Lee HK, Xiang C, Finniss S, Brodie C. The phosphorylation of tyrosine 332 is necessary for the caspase 3-dependent cleavage of PKCδ and the regulation of cell apoptosis. Cell Signal 19: 2165-2173, 2007.
46. Maeno Y, Li Q, Park K, Rask-Madsen C, Gao B, Matsumoto M, Liu Y, Wu IH, White MF, Feener EP, King GL. Inhibition of insulin signaling in endothelial cells by protein kinase C induced phosphorylation of p85 subunit of PI3-kinase. J Biol Chem 287: 4518-4530, 2012.
47. Malhotra R, D'Souza KM, Staron ML, Birukov KG, Bodi I, Akhter SA. Gαq-mediated activation of GRK2 by mechanical stretch in cardiac myocytes: the role of protein kinase C. J Biol Chem 285: 13748-13760, 2010.
48. Markou T, Yong CS, Sugden PH, Clerk A. Regulation of protein kinase C δ by phorbol ester, endothelin-1, and platelet-derived growth factor in cardiac myocytes. J Biol Chem 281: 8321-8331, 2006.
49. Mayr M, Metzler B, Chung YL, McGregor E, Mayr U, Troy H, Hu Y, Leitges M, Pachinger O, Griffiths JR, Dunn MJ, Xu Q. Ischemic preconditioning exaggerates cardiac damage in PKC-δ null mice. Am J Physiol Heart Circ Physiol 287: H946-H956, 2004.
50. Mima A, Ohshiro Y, Kitada M, Matsumoto M, Geraldes P, Li C, Li Q, White GS, Cahill C, Rask-Madsen C, King GL. Glomerular-specific protein kinase C-β-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity. Kidney Int 79: 883-896, 2011.
51. Murriel CL, Churchill E, Inagaki K, Szweda LI, Mochly-Rosen D. Protein kinase Cδ activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria. J Biol Chem 279: 47985-47991, 2004.
52. Newton AC. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J 370: 361-371, 2003.
53. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000.
54. 133 phosphorylation in the heart. J Biol Chem 283: 17009-17019, 2008.
55. Patel NA, Apostolatos HS, Mebert K, Chalfant CE, Watson JE, Pillay TS, Sparks J, Cooper DR. Insulin regulates protein kinase CβII alternative splicing in multiple target tissues: development of a hormonally responsive heterologous mini-gene. Mol Endocrinol 18: 899-911, 2004.
56. Ping P, Zhang J, Qiu Y, Tang XL, Manchikalapudi S, Cao X, Bolli R. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 81: 404-414, 1997.
57. Porter MJ, Heidkamp MC, Scully BT, Patel N, Martin JL, Samarel AM. Isoenzyme-selective regulation of SERCA2 gene expression by protein kinase C in neonatal rat ventricular myocytes. Am J Physiol Cell Physiol 285: C39-C47, 2003.
58. Robles-Flores M, Rendon-Huerta E, Gonzalez-Aguilar H, Mendoza-Hernandez G, Islas S, Men-doza V, Ponce-Castaneda MV, Gonzalez-Mariscal L, Lopez-Casillas F. p32 (gC1qBP) is a general protein kinase C (PKC)-binding protein. J Biol Chem 277: 5247-5255, 2002.
59. Roman BB, Geenen DL, Leitges M, Buttrick PM. PKCp is not necessary for cardiac hypertrophy. Am J Physiol Heart Circ Physiol 280: H2264-H2270, 2001.
60. Rybin VO, Guo J, Gertsberg Z, Elouardighi H, Steinberg SF. Protein kinase Ce{open} and Src control PKCδ activation loop phosphorylation in cardio-myocytes. J Biol Chem 282: 23631-23638, 2007.
61. 311 phosphorylation in cardiomyocyte caveolae. J Biol Chem 283: 17777-17788, 2008.
62. 295. Biochemistry 48: 4642-4651, 2009.
63. Rybin VO, Guo J, Sabri A, Elouardighi H, Schaefer E, Steinberg SF. Stimulus-specific differences in protein kinase C-δ localization and activation mechanisms in cardiomyocytes. J Biol Chem 279: 19350-19361, 2004.
64. Rybin VO, Steinberg SF. Do adult rat ventricular myocytes express protein kinase Cα? Am J Physiol Heart Circ Physiol 272: H2485-H2491, 1997.
65. Rybin VO, Steinberg SF. Protein kinase C isoform expression and regulation in the developing rat heart. Circ Res 74: 299-309, 1994.
66. Stebbins EG, Mochly-Rosen D. Binding specificity for RACK1 resides in the V5 region of βII protein kinase C. J Biol Chem 276: 29644-29650, 2001.
67. Steinberg SF. Distinctive activation mechanisms and functions for protein kinase C-δ. Biochem J 384: 449-459, 2004.
68. Steinberg SF. Structural basis of protein kinase C isoform function. Physiol Rev 88: 1341-1378, 2008.
69. Stempka L, Girod A, Muller HJ, Rincke G, Marks F, Gschwendt M, Bossemeyer D. Phosphorylation of protein kinase Cδ at threonine 505 is not a prerequisite for enzymatic activity. J Biol Chem 272: 6805-6811, 1997.
70. Sumandea MP, Pyle WG, Kobayashi T, de Tombe PP, Solaro RJ. Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T. J Biol Chem 278: 35135-35144, 2003.
71. Sumandea MP, Rybin VO, Hinken AC, Wang C, Kobayashi T, Harleton E, Sievert G, Balke CW, Feinmark SJ, Solaro RJ, Steinberg SF. Tyrosine phosphorylation modifies PKCδ-dependent phosphorylation of cardiac troponin I. J Biol Chem 283: 22680-22689, 2008.
72. Takeishi Y, Chu G, Kirkpatrick DM, Li Z, Wakasaki H, Kranias EG, King GL, Walsh RA. In vivo phosphorylation of cardiac troponin I by protein kinase CβII decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts. J Clin Invest 102: 72-78, 1998.
73. Takeishi Y, Jalili T, Ball NA, Walsh RA. Responses of cardiac protein kinase C isoforms to distinct pathological stimuli are differentially regulated. Circ Res 85: 264-271, 1999.
74. Takeishi Y, Ping P, Bolli R, Kirkpatrick DL, Hoit BD, Walsh RA. Transgenic overexpression of con-stitutively active protein kinase Ce causes concentric cardiac hypertrophy. Circ Res 86: 1218-1223, 2000.
75. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7: 85-96, 2006.
76. Wakasaki H, Koya D, Schoen FJ, Jirousek MR, Ways DK, Hoit BD, Walsh RA, King GL. Targeted overexpression of protein kinase CβII isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci USA 94: 9320-9325, 1997.
77. Way KJ, Isshiki K, Suzuma K, Yokota T, Zvagelsky D, Schoen FJ, Sandusky GE, Pechous PA, Vlahos CJ, Wakasaki H, King GL. Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C 32 activation and diabetes. Diabetes 51: 2709-2718, 2002.
78. Yamakawa H, Banno Y, Nakashima S, Yoshimura S, Sawada M, Nishimura Y, Nozawa Y, Sakai N. Crucial role of calpain in hypoxic PC12 cell death: calpain, but not caspases, mediates degradation of cytoskeletal proteins and protein kinase C-al-pha and -delta. Neurol Res 23: 522-530, 2001.
79. Yamamoto M, Acevedo-Duncan M, Chalfant CE, Patel NA, Watson JE, Cooper DR. The roles of protein kinase C-βI and - (3-II in vascular smooth muscle cell proliferation. Exp Cell Res 240: 349-358, 1998.
80. Yang L, Doshi D, Morrow J, Katchman A, Chen X, Marx SO. Protein kinase C isoforms differentially phosphorylate Cav1.2 α1c. Biochemistry 48: 6674-6683, 2009.
81. 1928 is a common site for Cav1.2 phosphorylation by protein kinase C isoforms. J Biol Chem 280: 207-214, 2005.
82. Zhang Y, Matkovich SJ, Duan X, Diwan A, Kang MY, Dorn GW. Receptor-independent protein kinase C-a signaling by calpain-generated free catalytic domains induces HDAC5 nuclear export and regulates cardiac transcription. J Biol Chem 286: 26943-26951, 2011.